|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 239/48 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2825042 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13761487.1 |
| Date of filing the European patent application | 2013-03-13 | |
| (97) | Date of publication of the European application | 2015-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation | 2018-12-10 |
| (86) | Number | PCT/US2013/030996 |
| Date | 2013-03-13 |
| (87) | Number | WO 2013/138502 |
| Date | 2013-09-19 |
| (30) | Number | Date | Country code |
| 201261611400 P | 2012-03-15 | US |
| (72) |
LAI, Mei, US
WITOWSKI, Steven, Richard, US
TESTER, Richland, Wayne, US
LEE, Kwangho, KR
|
| (73) |
Celgene CAR LLC,
AON House 30 Woodbourne Avenue, Pembroke HM 08,
BM
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Epidermio augimo faktoriaus receptoriaus kinazės slopiklio druskos |
| SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2022-02-18 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-03-13 |